Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice.
AUTOR(ES)
Filice, G A
RESUMO
Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P less than 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245100Documentos Relacionados
- Suppressive effect of secondary Toxoplasma gondii infection on antibody responses in mice.
- Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
- Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice.
- CR3-dependent resistance to acute Toxoplasma gondii infection in mice.
- Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
